417 related articles for article (PubMed ID: 28098811)
1. Aspalathin Protects the Heart against Hyperglycemia-Induced Oxidative Damage by Up-Regulating Nrf2 Expression.
Dludla PV; Muller CJ; Joubert E; Louw J; Essop MF; Gabuza KB; Ghoor S; Huisamen B; Johnson R
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098811
[TBL] [Abstract][Full Text] [Related]
2. The Transcription Profile Unveils the Cardioprotective Effect of Aspalathin against Lipid Toxicity in an In Vitro H9c2 Model.
Johnson R; Dludla PV; Muller CJ; Huisamen B; Essop MF; Louw J
Molecules; 2017 Jan; 22(2):. PubMed ID: 28146135
[TBL] [Abstract][Full Text] [Related]
3. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
4. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
[TBL] [Abstract][Full Text] [Related]
6. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1.
Li H; Yao W; Irwin MG; Wang T; Wang S; Zhang L; Xia Z
Free Radic Biol Med; 2015 Jul; 84():311-321. PubMed ID: 25795513
[TBL] [Abstract][Full Text] [Related]
8. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
9. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling.
Gao S; Yang Z; Shi R; Xu D; Li H; Xia Z; Wu QP; Yao S; Wang T; Yuan S
Eur J Pharmacol; 2016 May; 779():111-21. PubMed ID: 26973173
[TBL] [Abstract][Full Text] [Related]
10. Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis.
Johnson R; Dludla P; Joubert E; February F; Mazibuko S; Ghoor S; Muller C; Louw J
Mol Nutr Food Res; 2016 Apr; 60(4):922-34. PubMed ID: 26773306
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes.
Tsai CY; Wang CC; Lai TY; Tsu HN; Wang CH; Liang HY; Kuo WW
Int J Cardiol; 2013 Sep; 168(2):1286-97. PubMed ID: 23453443
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Nrf2-ARE Pathway Ameliorates Hyperglycemia-Mediated Mitochondrial Dysfunction in Podocytes Partly Through Sirt1.
Zhang Q; Deng Q; Zhang J; Ke J; Zhu Y; Wen RW; Ye Z; Peng H; Su ZZ; Wang C; Lou T
Cell Physiol Biochem; 2018; 48(1):1-15. PubMed ID: 29996125
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
[TBL] [Abstract][Full Text] [Related]
14. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
15. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
Guo Y; Zhuang X; Huang Z; Zou J; Yang D; Hu X; Du Z; Wang L; Liao X
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
[TBL] [Abstract][Full Text] [Related]
16. Bakuchiol Alleviates Hyperglycemia-Induced Diabetic Cardiomyopathy by Reducing Myocardial Oxidative Stress via Activating the SIRT1/Nrf2 Signaling Pathway.
Ma W; Guo W; Shang F; Li Y; Li W; Liu J; Ma C; Teng J
Oxid Med Cell Longev; 2020; 2020():3732718. PubMed ID: 33062139
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes.
Tsai CY; Wen SY; Cheng SY; Wang CH; Yang YC; Viswanadha VP; Huang CY; Kuo WW
J Cell Biochem; 2017 Jul; 118(7):1659-1669. PubMed ID: 27859591
[TBL] [Abstract][Full Text] [Related]
19. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
20. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
Jin A; Li B; Li W; Xiao D
Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]